Filter
1010
Filtered Results: 1010
Text search:
sérologie
Featured
Recommendations
123
New Publications
267
Language
Document type
No document type
514
Guidelines
261
Studies & Reports
111
Manuals
47
Fact sheets
34
Strategic & Response Plan
26
Situation Updates
7
Infographics
5
Training Material
3
Brochures
1
Resource Platforms
1
Countries / Regions
Global
37
Germany
35
Latin America and the Carribbean
32
India
32
Africa
23
Colombia
20
South Africa
20
Western and Central Europe
19
Nigeria
18
Congo, Democratic Republic of
17
Philippines
16
Senegal
15
Bangladesh
15
Paraguay
14
Argentina
14
Ethiopia
13
Nepal
10
Mozambique
10
West and Central Africa
10
Bolivia
10
Indonesia
10
Kenya
9
Sierra Leone
9
Rwanda
9
Burkina Faso
9
Peru
9
Venezuela
9
Tanzania
9
East and Southern Africa
9
Brazil
9
Central African Republic
9
Guinea
8
Zambia
8
Uganda
7
Haiti
6
Eastern Europe
6
Madagascar
6
Ukraine
5
Benin
5
Cameroon
5
Malawi
5
Middle East and North Africa
5
Russia
5
Liberia
5
Myanmar / Burma
5
Lesotho
4
Ghana
4
Syria
4
Asia
4
South–East Asia Region
4
France
4
Spain
4
Angola
4
Ecuador
4
Pakistan
4
China
3
Afghanistan
3
USA
3
Cambodia
3
Côte d’Ivoire / Ivory Coast
3
Vietnam
3
Namibia
3
North Macedonia
2
Mexico
2
El Salvador
2
Turkey
2
Iran
2
Albania
2
Zimbabwe
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
Portugal
2
Lebanon
2
Egypt
2
Sudan
2
Mali
2
South Sudan
2
Iraq
2
Tajikistan
1
Togo
1
Chile
1
Laos
1
Morocco
1
Qatar
1
Italy
1
Guinea-Bissau
1
Tunisia
1
United Kingdom
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Chad
1
Libya
1
Bhutan
1
Botswana
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
397
Clinical Guidelines
160
Pharmacy & Technologies
45
Public Health
27
Women & Child Health
19
Key Resources
15
Capacity Building
5
Toolboxes
COVID-19
155
NTDs
112
HIV
97
Rapid Response
83
Zika
56
TB
48
Ebola
39
Refugee
23
AMR
14
Planetary Health
13
Pharmacy
13
Caregiver
10
Mental Health
9
Cholera
8
Polio
8
Natural Hazards
3
Global Health Education
3
Disability
2
NCDs
2
Conflict
2
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom...
